In people with early MS, diet may correlate with biological aging and the development of disease-related disability, study ...
Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results